Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic vs Brand Name Antihypertensives in Hypertension
NCT02853045Phase 4Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Jun 2015
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by CHU Saint-Etienne. Primary endpoint: Measure of systolic blood pressure at 24 hours. Started Jun 2015; status: completed.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02853045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02853045.